Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eli Lilly & Co (LLY)  
$905.38 3.66 (0.4%) as of 4:30 Fri 6/28


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 956,580,000
Market Cap: 866.07(B)
Last Volume: 3,374,911 Avg Vol: 3,268,697
52 Week Range: $434.7 - $909.04
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  720
Guru Rank Value     : 1.4
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 656
Total Buy Value $0 $0 $0 $199,549
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 1,520,577 2,391,327 3,771,329 6,318,238
Total Sell Value $1,284,658,855 $1,892,909,435 $2,147,483,647 $2,147,483,647
Total People Sold 3 3 4 6
Total Sell Transactions 18 31 50 93
End Date 2024-03-31 2023-12-29 2023-06-30 2022-06-30

   
Records found: 1436
  Page 49 of 58  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mahony Susan SVP & Pres., Lilly Oncology   •       –      –    2016-01-26 4 A $81.96 $94,172 I/I 1,149 9,533     -
   Mahony Susan SVP & Pres., Lilly Oncology   •       –      –    2016-01-26 4 A $81.96 $1,564,862 D/D 19,093 81,681     -
   Alvarez Ralph Director   –       •      –    2015-12-31 4 A $86.04 $9,895 D/D 115 30,552     -
   Lilly Endowment Inc 10% Owner   –       –       •   2015-12-21 4 S $86.00 $17,630,000 D/D (205,000) 127,860,804     -
   Ricks David A SVP and Pres, Lilly Bio-Meds   •       –      –    2015-12-17 5 GD $0.00 $0 D/D 72 60,933     -
   Lilly Endowment Inc 10% Owner   –       –       •   2015-12-15 4 S $85.60 $18,402,925 D/D (215,000) 128,065,804     -
   Rice Derica W EVP-Global Services and CFO   •       –      –    2015-12-11 5/A A $0.00 $0 I/I 66 329,206     -
   Rice Derica W EVP-Global Services and CFO   •       –      –    2015-12-11 5 GD $0.00 $0 I/I 66 329,140     -
   Conterno Enrique A Sr. VP & Pres., Lilly Diabetes   •       –      –    2015-12-09 4 S $83.88 $2,097,000 D/D (25,000) 88,131     -
   Rice Derica W EVP-Global Services and CFO   •       –      –    2015-12-02 5 GD $0.00 $0 I/I 11,596 329,206     -
   Lilly Endowment Inc 10% Owner   –       –       •   2015-12-02 4 S $84.87 $17,869,068 D/D (210,000) 128,280,804     -
   Seifert Kathi P Director   –       •      –    2015-11-30 4 A $81.23 $144,996 D/D 1,785 61,099     -
   Tai Jackson P Director   –       •      –    2015-11-30 4 A $81.23 $144,996 D/D 1,785 36,301     -
   Runge Marschall S Director   –       •      –    2015-11-30 4 A $81.23 $144,996 D/D 1,785 4,976     -
   Prendergast Franklyn G Director   –       •      –    2015-11-30 4 A $81.23 $144,996 D/D 1,785 63,139     -
   Marram Ellen R Director   –       •      –    2015-11-30 4 A $81.23 $144,996 D/D 1,785 45,586     -
   Hoover R David Director   –       •      –    2015-11-30 4 A $81.23 $144,996 D/D 1,785 30,610     -
   Kaelin William G Jr Director   –       •      –    2015-11-30 4 A $81.23 $144,996 D/D 1,785 8,930     -
   Horn Karen N Director   –       •      –    2015-11-30 4 A $81.23 $144,996 D/D 1,785 73,166     -
   Fyrwald J Erik Director   –       •      –    2015-11-30 4 A $81.23 $144,996 D/D 1,785 50,999     -
   Eskew Michael L Director   –       •      –    2015-11-30 4 A $81.23 $144,996 D/D 1,785 31,107     -
   Baicker Katherine Director   –       •      –    2015-11-30 4 A $81.23 $144,996 D/D 1,785 10,331     -
   Alvarez Ralph Director   –       •      –    2015-11-30 4 A $81.23 $154,906 D/D 1,907 30,272     -
   Harrington Michael J Senior VP and General Counsel   •       –      –    2015-11-25 5 GD $0.00 $0 D/D 2,276 37,082     -
   Walsh Fionnuala M SVP, Global Quality   •       –      –    2015-11-23 4 D $84.47 $627,950 D/D (7,434) 43,409     -
  1436 Records found
  Previous  40  41  42  43  44  45  46  47  48  49  Next   
  Page 49 of 58
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us